FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri
- PMID: 27353144
- PMCID: PMC5061717
- DOI: 10.1002/mbo3.371
FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri
Abstract
Bacterial-derived compounds from the intestinal microbiome modulate host mucosal immunity. Identification and mechanistic studies of these compounds provide insights into host-microbial mutualism. Specific Lactobacillus reuteri strains suppress production of the proinflammatory cytokine, tumor necrosis factor (TNF), and are protective in a mouse model of colitis. Human-derived L. reuteri strain ATCC PTA 6475 suppresses intestinal inflammation and produces 5,10-methenyltetrahydrofolic acid polyglutamates. Insertional mutagenesis identified the bifunctional dihydrofolate synthase/folylpolyglutamate synthase type 2 (folC2) gene as essential for 5,10-methenyltetrahydrofolic acid polyglutamate biosynthesis, as well as for suppression of TNF production by activated human monocytes, and for the anti-inflammatory effect of L. reuteri 6475 in a trinitrobenzene sulfonic acid-induced mouse model of acute colitis. In contrast, folC encodes the enzyme responsible for folate polyglutamylation but does not impact TNF suppression by L. reuteri. Comparative transcriptomics between wild-type and mutant L. reuteri strains revealed additional genes involved in immunomodulation, including previously identified hdc genes involved in histidine to histamine conversion. The folC2 mutant yielded diminished hdc gene cluster expression and diminished histamine production, suggesting a link between folate and histadine/histamine metabolism. The identification of genes and gene networks regulating production of bacterial-derived immunoregulatory molecules may lead to improved anti-inflammatory strategies for digestive diseases.
Keywords: folC2; Colitis; Lactobacillus reuteri.; folate; histamine; immunomodulation.
© 2016 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5061717/bin/MBO3-5-802-g006.gif)
Similar articles
-
Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.mBio. 2015 Dec 15;6(6):e01358-15. doi: 10.1128/mBio.01358-15. mBio. 2015. PMID: 26670383 Free PMC article.
-
Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.J Bacteriol. 2013 Dec;195(24):5567-76. doi: 10.1128/JB.00261-13. Epub 2013 Oct 11. J Bacteriol. 2013. PMID: 24123819 Free PMC article.
-
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling.PLoS One. 2012;7(2):e31951. doi: 10.1371/journal.pone.0031951. Epub 2012 Feb 22. PLoS One. 2012. PMID: 22384111 Free PMC article.
-
Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.Medicina (Kaunas). 2021 Aug 5;57(8):802. doi: 10.3390/medicina57080802. Medicina (Kaunas). 2021. PMID: 34441008 Free PMC article. Review.
-
Next-Generation Probiotic Therapy to Protect the Intestines From Injury.Front Cell Infect Microbiol. 2022 Jun 28;12:863949. doi: 10.3389/fcimb.2022.863949. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35837474 Free PMC article. Review.
Cited by
-
The Plethora of Microbes with Anti-Inflammatory Activities.Int J Mol Sci. 2024 Mar 4;25(5):2980. doi: 10.3390/ijms25052980. Int J Mol Sci. 2024. PMID: 38474227 Free PMC article. Review.
-
Folate-producing bifidobacteria: metabolism, genetics, and relevance.Microbiome Res Rep. 2023 Dec 12;3(1):11. doi: 10.20517/mrr.2023.59. eCollection 2024. Microbiome Res Rep. 2023. PMID: 38455078 Free PMC article. Review.
-
Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling.Gut Microbes. 2023 Dec;15(2):2256043. doi: 10.1080/19490976.2023.2256043. Gut Microbes. 2023. PMID: 37698879 Free PMC article.
-
Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion.J Nanobiotechnology. 2023 Aug 31;21(1):309. doi: 10.1186/s12951-023-02065-0. J Nanobiotechnology. 2023. PMID: 37653406 Free PMC article.
-
Intergenerational association of gut microbiota and metabolism with perinatal folate metabolism and neural tube defects.iScience. 2023 Jul 29;26(9):107514. doi: 10.1016/j.isci.2023.107514. eCollection 2023 Sep 15. iScience. 2023. PMID: 37636040 Free PMC article.
References
-
- Arnold, R. J. , and Reilly J. P.. 2000. Observation of tetrahydrofolylpolyglutamic acid in bacteria cells by matrix‐assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 281:45–54. - PubMed
-
- Bibiloni, R. , Fedorak R. N., Tannock G. W., Madsen K. L., Gionchetti P., Campieri M., et al., 2005. VSL#3 probiotic‐mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100:1539–1546. - PubMed
-
- Bleau, C. , Monges A., Rashidan K., Laverdure J. P., M. Lacroix , Van Calsteren M. R., et al., 2010. Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW‐9595M increase IL‐10 production by macrophages. J. Appl. Microbiol. 108:666–675. - PubMed
-
- Bognar, A. L. , and Shane B.. 1986. Bacterial folylpoly(gamma‐glutamate) synthase‐dihydrofolate synthase. Methods Enzymol. 122:349–359. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources